Government urged to revamp positive list system

Published: 2008-07-10 06:58:00

Updated: 2008-07-10 06:58:00

Korea should revise the current positive list system so that domestic drug makers will be able to focus on research and development of new drugs to survive in an era of the free trade agreement, according to the Korea Pharmaceutical Manufacturers Association.

Under the current drug pricing sys...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK